• Latest
  • Saved Stories
  • Search

    • Associate Professor Justin Denholm

    Medical Director, Victorian Tuberculosis Program at Melbourne Health; Principal Research Fellow, Department of Microbiology and Immunology, University of Melbourne; The Peter Doherty Institute for Infection and Immunity

    See research profile
    Q&A: Dexamethasone and COVID-19 thumbnail image

    Health & Medicine

    |

    Q&A

    Q&A: Dexamethasone and COVID-19

    According to a trial in the UK, dexamethasone is “the first drug shown to improve survival in COVID-19” patients. But what is it and what do these results tell us?

    From decades to days: 3D modelling tuberculosis thumbnail image

    Health & Medicine

    From decades to days: 3D modelling tuberculosis

    3D modelling of the mutations in TB means doctors around the world could soon tailor individual treatments for the disease in a matter of days, rather than years

    Tuberculosis: Still a major killer thumbnail image

    Health & Medicine

    Tuberculosis: Still a major killer

    Researchers for first time show the significant burden of tuberculosis on adolescents and young adults, a group often ignored in disease control efforts

    Subscribe for your weekly email digest

    By subscribing, you agree to our

    Acknowledgement of country

    We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

    Read about our Indigenous priorities
    Phone: 13 MELB (13 6352) | International: +61 3 9035 5511The University of Melbourne ABN: 84 002 705 224CRICOS Provider Code: 00116K (visa information)